课题基金 / 基金详情

CRISPR-GWAS: Leveraging genome-editing to identify disease-causing genes

CRISPR-GWAS: Leveraging genome-editing to identify disease-causing genes
CRISPR-GWAS：利用基因组编辑来识别致病基因
批准号：
396803
负责人：
Morris John A
金额：
$10.93万
依托单位：
New York Genome Center (New York, NY)
依托单位国家：
加拿大
项目类别：
Fellowship Programs
财政年份：
2018
资助国家：
加拿大
项目状态：
已结题
起止时间：
2018-11-01 至 2021-11-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=396803&lang=en
关键词：
Blood Genetics Causal Snps Crispr Epigenomics Fine-Mapping Functional Genomics Genome-Editing Genome-Wide Association Study Non-Coding Genome Xcas9

项目摘要

项目成果

Morris John A的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The discovery of disease-causing genes is crucial to understand how diseases function and to design new drug targets. Over the past decade, researchers have performed large genetic studies, looking at DNA base pair differences that commonly occur in the p
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CRISPR-GWAS: Leveraging genome-editing to identify disease-causing genes
Identifying Molecular Genetic Pathways and Modifiable Risk Factors of Osteoporosis Through Genome-Wide Association and Mendelian Randomization
海外基金